|
Fusion gene ID: 3750 |
FusionGeneSummary for B4GALT5_PTGIS |
Fusion gene summary |
Fusion gene information | Fusion gene name: B4GALT5_PTGIS | Fusion gene ID: 3750 | Hgene | Tgene | Gene symbol | B4GALT5 | PTGIS | Gene ID | 9334 | 5740 |
Gene name | beta-1,4-galactosyltransferase 5 | prostaglandin I2 synthase | |
Synonyms | B4Gal-T5|BETA4-GALT-IV|beta4Gal-T5|beta4GalT-V|gt-V | CYP8|CYP8A1|PGIS|PTGI | |
Cytomap | 20q13.13 | 20q13.13 | |
Type of gene | protein-coding | protein-coding | |
Description | beta-1,4-galactosyltransferase 5UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 5UDP-Gal:betaGlcNAc beta 1,4-galactosyltransferase, polypeptide 5UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 5beta-1,4-GalT IIbeta-1,4-GalT I | prostacyclin synthasecytochrome P450, family 8, subfamily A, polypeptide 1prostaglandin I2 (prostacyclin) synthase | |
Modification date | 20180522 | 20180523 | |
UniProtAcc | O43286 | Q16647 | |
Ensembl transtripts involved in fusion gene | ENST00000371711, | ENST00000244043, ENST00000478971, | |
Fusion gene scores | * DoF score | 14 X 9 X 9=1134 | 4 X 3 X 3=36 |
# samples | 14 | 4 | |
** MAII score | log2(14/1134*10)=-3.01792190799726 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(4/36*10)=0.15200309344505 effective Gene in Pan-Cancer Fusion Genes (eGinPCFGs). DoF>8 and MAII>0 | |
Context | PubMed: B4GALT5 [Title/Abstract] AND PTGIS [Title/Abstract] AND fusion [Title/Abstract] | ||
Functional or gene categories assigned by FusionGDB annotation |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
Partner | Gene | GO ID | GO term | PubMed ID |
Tgene | PTGIS | GO:0001516 | prostaglandin biosynthetic process | 20122998|21296955 |
Tgene | PTGIS | GO:0032088 | negative regulation of NF-kappaB transcription factor activity | 20159982 |
Tgene | PTGIS | GO:0035360 | positive regulation of peroxisome proliferator activated receptor signaling pathway | 11551955 |
Tgene | PTGIS | GO:0045019 | negative regulation of nitric oxide biosynthetic process | 20159982 |
Tgene | PTGIS | GO:0050728 | negative regulation of inflammatory response | 20159982 |
Tgene | PTGIS | GO:0071456 | cellular response to hypoxia | 21296955 |
Tgene | PTGIS | GO:0097190 | apoptotic signaling pathway | 11551955 |
Tgene | PTGIS | GO:1900119 | positive regulation of execution phase of apoptosis | 11551955 |
Fusion gene information from three resources (ChiTars (NAR, 2018), tumorfusions (NAR, 2018), Gao et al. (Cell, 2018)) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Data type | Source | Cancer type | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
TCGA | LD | BRCA | TCGA-AN-A0AM-01A | B4GALT5 | chr20 | 48330113 | - | PTGIS | chr20 | 48166726 | - |
* LD: Li Ding group's fusion gene list RV: Roel Verhaak group's fusion gene list ChiTaRs fusion database |
Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
Frame-shift | ENST00000371711 | ENST00000244043 | B4GALT5 | chr20 | 48330113 | - | PTGIS | chr20 | 48166726 | - |
5CDS-5UTR | ENST00000371711 | ENST00000478971 | B4GALT5 | chr20 | 48330113 | - | PTGIS | chr20 | 48166726 | - |
Top |
FusionProtFeatures for B4GALT5_PTGIS |
Main function of each fusion partner protein. (from UniProt) |
Hgene | Tgene |
B4GALT5 | PTGIS |
Responsible for the synthesis of complex-type N-linkedoligosaccharides in many glycoproteins as well as the carbohydratemoieties of glycolipids. {ECO:0000269|PubMed:9435216}. | Catalyzes the isomerization of prostaglandin H2 toprostacyclin (= prostaglandin I2). {ECO:0000269|PubMed:18032380,ECO:0000269|PubMed:25623425}. |
Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at . * Minus value of BPloci means that the break pointn is located before the CDS. |
- In-frame and retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
- In-frame and not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
FusionGeneSequence for B4GALT5_PTGIS |
For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. (nt: nucleotides, aa: amino acids) |
* Fusion amino acid sequences. |
* Fusion transcript sequences (only coding sequence (CDS) region). |
* Fusion transcript sequences (Full-length transcript). |
Top |
FusionGenePPI for B4GALT5_PTGIS |
Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in . |
Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
Hgene | Hgene's interactors | Tgene | Tgene's interactors |
B4GALT5 | ELAVL1, HLA-DPA1, NXPH2, IL20RB, GINM1, TNF, LIPH, IL27RA, FCGRT, SLC39A9, KIAA1467, IL13RA2, SYT12, KERA, GABRG2, CRP, HSPA13, MGAT4C, AVP, TPCN2, TRIM25 | PTGIS | APP, PTGS2, PTGS1, CAV1 |
- Retained PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
- Lost PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
- Retained PPIs, but lost function due to frame-shift fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
RelatedDrugs for B4GALT5_PTGIS |
Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.0 2018-04-02) |
Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Tgene | PTGIS | Q16647 | DB01240 | Epoprostenol | Prostacyclin synthase | small molecule | approved |
Tgene | PTGIS | Q16647 | DB00812 | Phenylbutazone | Prostacyclin synthase | small molecule | approved|vet_approved |
Top |
RelatedDiseases for B4GALT5_PTGIS |
Diseases associated with fusion partners. (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Hgene | B4GALT5 | C0023893 | Liver Cirrhosis, Experimental | 1 | CTD_human |
Hgene | B4GALT5 | C3495559 | Juvenile arthritis | 1 | CTD_human |
Tgene | PTGIS | C0000786 | Spontaneous abortion | 1 | CTD_human |
Tgene | PTGIS | C0013274 | Patent ductus arteriosus | 1 | CTD_human |
Tgene | PTGIS | C0024121 | Lung Neoplasms | 1 | CTD_human |
Tgene | PTGIS | C0038325 | Stevens-Johnson Syndrome | 1 | CTD_human |